Postoperative Outcomes of Covid-19 Patients Who Were Hospitalized in a Training and Research Hospital, Who Were Operated on Electively

September 24, 2022 updated by: Senay Canikli, Samsun University
The Covid-19 infection has led to global health crisis. As the number of patients recovering from Covid-19 infection increases, it is necessary to create an understanding of the health problems that concern them. Reports of persistent and long-lasting effects are increasing after Covid-19 infection .

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Data on postoperative outcomes in the patient population with Covid-19 infection are limited. In more than half of these patients, pulmonary complications and mortality are seen between 19-24%. Covid-19 infection positivity has been shown as an independent risk factor for surgical mortality. In this study, we aimed to examine the results of patients who were hospitalized and operated electively after they has Covid-19. Among the patients who were hospitalized and followed up in our hospital due to Covid-19 infection between July 2020 and July 2021, those over the age 18 and opereted on electively will be included in the study. By accessing the hospital records, patients Covid-19 treatment records, length of hospital stay, intensive care follow-up, processes, pulmonary support conditions, lung involvement, time until the operation, operation type, operation time, ASA classification, anesthesia type, post-operative follow-up processes, post-operation intensive care needs, time to discharge and mortality will be examined. After the data of of the patients were recorded using SPSS19 program, statistical analysis will be performed using the arithmetic mean, median, standart deviation and Chi-square test, which are among the measures of distribution and prevalence.

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ilkadım
      • Samsun, Ilkadım, Turkey
        • Samsun University Samsun Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

the files of the patients who were hospitalized in the hospital and who had an additional operation, among the patients who had Covid-19, will be reviewed retrospectively

Description

Inclusion Criteria:

  • over 18 years old
  • those who elective surgery
  • patients who have had Covid-19

Exclusion Criteria:

  • emergency surgery
  • under 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
post-covid elective surgery patients
data of postcovid patients underwent elective surgery will be collected.
posotcovid patients will be elective surgery postoperative outcomes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
need for postoperative intensive care
Time Frame: 8 months
after covid-19, the need for postoperative intensive care unit is higer, especially due to pulmonary complications.
8 months
prolongation of postoperative hospital stay
Time Frame: 8 months
longer hospital stay, especially due to pulmonary complications
8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anesthesia preference status; general or spinal
Time Frame: 8 months
more regional anesthesia techniques are preferred due to increased risk of pulmonary complications after Covid-19 infection
8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: şenay canikli adıgüzel, Project manager

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 15, 2022

Primary Completion (ACTUAL)

August 20, 2022

Study Completion (ACTUAL)

August 20, 2022

Study Registration Dates

First Submitted

May 10, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (ACTUAL)

May 12, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 27, 2022

Last Update Submitted That Met QC Criteria

September 24, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

personal data of participants will not be shared. Patient files will be coded by giving sequence numbers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Long-term Consequences of COVID-19 Infection

Clinical Trials on descriptive

Subscribe